|
Delayed
Hong Kong S.E.
08:56:56 13/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 20.88 HKD | +0.38% |
|
+1.36% | -31.50% |
| 09-24 | Medtide Acquires China Land, Property for Peptide CDMO Project | MT |
| 09-24 | Medtide Inc. Announces Resignation of Li Lingmei as Executive Director, Effective September 24, 2026 | CI |
Company Valuation: Medtide Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 3,884 | 2,516 | - | - |
| Change | - | -35.22% | - | - |
| Enterprise Value (EV) 1 | 3,027 | 1,937 | 1,867 | 1,771 |
| Change | - | -36% | -3.62% | -5.13% |
| P/E | - | - | - | - |
| PBR | 2.31x | 1.33x | 1.16x | 1x |
| PEG | - | - | - | - |
| Capitalization / Revenue | 6.81x | 4.2x | 3.39x | 2.82x |
| EV / Revenue | 5.31x | 3.24x | 2.52x | 1.99x |
| EV / EBITDA | 12.6x | 8.42x | 5.96x | 4.57x |
| EV / EBIT | 14.2x | 9.41x | 6.71x | 5.21x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | - | - |
| Distribution rate | - | - | - | - |
| Net sales 1 | 570.1 | 598.6 | 742.3 | 890.7 |
| EBITDA 1 | 240.2 | 229.9 | 313.1 | 387.5 |
| EBIT 1 | 212.4 | 205.9 | 278.3 | 340.2 |
| Net income | - | - | - | - |
| Net Debt 1 | -857.2 | -578.9 | -649 | -744.7 |
| Reference price 2 | 27.39 | 17.74 | 17.74 | 17.74 |
| Nbr of stocks (in thousands) | 141,800 | 141,800 | - | - |
| Announcement Date | 3/30/26 A | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 3.96x | 10.31x | -.--% | 376M | |
| 20.5x | 7.3x | 14.66x | 1.45% | 70.65B | |
| 27.57x | 7.54x | 23.67x | 0.05% | 51.22B | |
| 33.47x | 6.01x | 18.01x | 0.97% | 48.04B | |
| 33.77x | 3.27x | 14.13x | -.--% | 43.16B | |
| -20.11x | 203.7x | -21.41x | -.--% | 41.57B | |
| 46.41x | 5.27x | 28.96x | -.--% | 39.84B | |
| 27.3x | 7.78x | 20.18x | 0.42% | 30.87B | |
| 31.79x | 6.78x | 17.59x | -.--% | 27.53B | |
| -14.56x | 5.85x | -7.07x | -.--% | 24.08B | |
| Average | 20.68x | 25.75x | 11.90x | 0.29% | 37.73B | |
| Weighted average by Cap. | 22.04x | 28.04x | 13.06x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3880 Stock
- Valuation Medtide Inc.
Select your edition
All financial news and data tailored to specific country editions
